Completing data — refresh the page later to see the latest
101975-10-4COc1cc(-c2ccc(=O)[nH]n2)ccc1OC(F)FHJMQDJPMQIHLPB-UHFFFAOYSA-NZardaverine is a pyridazinone derivative in which pyridazin-3(2H)-one is substituted at C-6 with a 4-(difluoromethoxy)-3-methoxyphenyl group. It is a phosphodiesterase inhibitor, selective for PDE3 and 4. It has a role as a bronchodilator agent, a peripheral nervous system drug, an anti-asthmatic drug and an EC 3.1.4.* (phosphoric diester hydrolase) inhibitor. It is a pyridazinone and an organofluorine compound.
101975-10-4Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Agents that cause an increase in the expansion of a bronchus or bronchial tubes.
Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases.
UsesZardaverine can selectively inhibitphosphodiesterase III (PDE III) from human platelets andphosphodiesterase IV (PDE IV) from human polymorphonuclear leucocytes (PMN).
UsesBronchodilator;Phosphodiesterase III inhibitor
DefinitionChEBI: A pyridazinone derivative in which pyridazin-3(2H)-one is substituted at C-6 with a 4-(difluoromethoxy)-3-methoxyphenyl group. It is a phosphodiesterase inhibitor, selective for PDE3 and 4.
DTXSID8042559CHEMBL313842CHEBI:46548